A drug just approved for pancreatic cancer opens a new chapter in treatment

NPR | By Yuki Noguchi

Published August 27, 2026 at 4:16 PM EDT

The FDA just approved a breakthrough drug for metastatic pancreatic cancer, which is notoriously hard to treat. In clinical trials, the new pill roughly doubled how long patients survived.

Yuki Noguchi

Yuki Noguchi is a correspondent on the Science Desk based out of NPR's headquarters in Washington, D.C.

See stories by Yuki Noguchi

Support nonprofit, fact-based public service journalism

WEKU depends on support from those who view and listen to our content. There's no paywall here. Please support WEKU with your donation.

Contribute now

Related Content

Ratko Mladic, the 'Butcher of Bosnia' convicted of genocide, is dead at 84

Tom Gjelten

The "Butcher of Bosnia" is dead — Ratko Mladic, the Bosnian Serb commander convicted of genocide, has died at 84 while serving a life sentence in The Hague.
Scientists map the interactions of key proteins linked with profound autism

Pien Huang

After more than a decade, UCSF scientists have mapped around 100 varied genes associated with profound autism to a smaller set of biological pathways, offering a promising path for developing drugs.
The Sisyphean path it took to get 'Coyote vs. Acme' to the big screen

Sam Yellowhorse Kesler, Wailin Wong

Warner Brothers' decision three years ago to shelve a live action animated movie with Wile E. Coyote and the Roadrunner upset many fans. Here's what its release tells us about Hollywood economics.
Syria's breakaway Kurds relinquish autonomy and rejoin the country

Jane Arraf

Syria's Kurds, once backed by the U.S. to fight ISIS, have relinquished autonomy and dissolved their army to rejoin Syria.
Political bickering follows two deaths related to measles in Pennsylvania

Maria Godoy

This week, Pennsylvania officials reported two measles-related deaths. Those deaths have now become wrapped up in politics. The country is in the midst of a record-setting number of measles cases.